Intuitive Surgical Inc (ISRG)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $153.77B
Last updated: Nov 17, 2026 at 11:06 AM ET
Intuitive Surgical Inc (ISRG) Earnings: Report Dates and Results
Intuitive Surgical (ISRG) is expected to report earnings on Jan 20, 2027. In the quarter ended Sep 30, 2026, Intuitive Surgical reported EPS of $3.00, above the $2.13 estimate. It beat the EPS estimate in each of the last 15 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ISRG has an expected report date of Jan 20, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 19.0% above the $2.53 reported for the quarter ended Dec 31, 2025.
ISRG Earnings Call
The latest ISRG earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, ISRG beat 36 and missed 4. Revenue for the quarter ended Sep 30, 2026 was $3.05B, up 21.5% from $2.51B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $3.00 | $2.13 | N/A | +40.85% | Beat | +25.0% | 24 | 1 up, 0 down | Oct 20, 2026 | $3.05B |
| Jun 30, 2026 | $2.80 | $2.02 | N/A | +38.61% | Beat | +27.9% | 23 | 2 up, 0 down | Jul 16, 2026 | $2.89B |
| Mar 31, 2026 | $2.50 | $2.11 | $2.03 - $2.29 | +18.48% | Beat | +38.1% | 24 | 1 up, 0 down | Apr 21, 2026 | $2.77B |
| Dec 31, 2025 | $2.53 | $2.27 | $2.13 - $2.45 | +11.45% | Beat | +14.5% | 26 | 5 up, 0 down | Jan 22, 2026 | $2.87B |
| Sep 30, 2025 | $2.40 | $1.99 | $1.85 - $2.11 | +20.60% | Beat | +30.4% | 24 | 0 up, 1 down | Oct 21, 2025 | $2.51B |
| Jun 30, 2025 | $2.19 | $1.92 | $1.87 - $2.12 | +14.06% | Beat | +23.0% | 25 | 1 up, 0 down | Jul 22, 2025 | $2.44B |
| Mar 31, 2025 | $1.81 | $1.73 | $1.58 - $1.87 | +4.62% | Beat | +20.7% | 24 | 2 up, 3 down | Apr 22, 2025 | $2.25B |
| Dec 31, 2024 | $2.21 | $1.79 | $1.64 - $1.98 | +23.46% | Beat | +38.1% | 25 | 6 up, 0 down | Jan 23, 2025 | $2.41B |
| Sep 30, 2024 | $1.84 | $1.64 | $1.53 - $1.72 | +12.20% | Beat | +26.0% | 23 | 0 up, 1 down | Oct 17, 2024 | $2.04B |
| Jun 30, 2024 | $1.78 | $1.54 | $1.48 - $1.61 | +15.58% | Beat | +25.4% | 23 | 2 up, 0 down | Jul 18, 2024 | $2.01B |
| Mar 31, 2024 | $1.50 | $1.42 | $1.30 - $1.54 | +5.63% | Beat | +22.0% | 20 | 0 up, 0 down | Apr 18, 2024 | $1.89B |
| Dec 31, 2023 | $1.60 | $1.49 | $1.40 - $1.56 | +7.38% | Beat | +30.1% | 22 | 6 up, 0 down | Jan 23, 2024 | $1.93B |
| Sep 30, 2023 | $1.46 | $1.42 | $1.34 - $1.50 | +2.82% | Beat | +22.7% | 22 | 0 up, 3 down | Oct 19, 2023 | $1.74B |
| Jun 30, 2023 | $1.42 | $1.33 | $1.23 - $1.37 | +6.77% | Beat | +24.6% | 21 | 0 up, 0 down | Jul 20, 2023 | $1.76B |
| Mar 31, 2023 | $1.23 | $1.20 | $1.15 - $1.25 | +2.50% | Beat | +8.8% | 18 | 2 up, 1 down | Apr 18, 2023 | $1.70B |
| Dec 31, 2022 | $1.23 | $1.25 | $1.14 - $1.32 | -1.60% | Miss | -5.4% | 18 | 2 up, 1 down | Jan 24, 2023 | $1.66B |
| Sep 30, 2022 | $1.19 | $1.12 | $1.06 - $1.22 | +6.25% | Beat | 0.0% | 19 | 2 up, 1 down | Oct 18, 2022 | $1.56B |
| Jun 30, 2022 | $1.14 | $1.20 | $1.09 - $1.27 | -5.00% | Miss | -13.0% | 16 | 1 up, 0 down | Jul 21, 2022 | $1.52B |
| Mar 31, 2022 | $1.13 | $1.08 | $1.02 - $1.13 | +4.63% | Beat | -3.4% | 17 | 0 up, 1 down | Apr 21, 2022 | $1.49B |
| Dec 31, 2021 | $1.30 | $1.28 | $1.21 - $1.32 | +1.56% | Beat | +9.2% | 14 | 3 up, 0 down | Jan 20, 2022 | $1.55B |
| Sep 30, 2021 | $1.19 | $1.16 | $1.07 - $1.29 | +2.59% | Beat | +29.3% | 15 | N/A | Oct 19, 2021 | $1.40B |
| Jun 30, 2021 | $1.31 | $1.02 | $0.92 - $1.17 | +28.43% | Beat | +254.1% | 15 | N/A | Jul 20, 2021 | $1.46B |
| Mar 31, 2021 | $1.17 | $0.88 | $0.77 - $0.94 | +32.95% | Beat | +30.0% | 15 | N/A | Apr 20, 2021 | $1.29B |
| Dec 31, 2020 | $1.19 | $1.04 | $0.97 - $1.13 | +14.42% | Beat | +2.6% | 15 | N/A | Jan 21, 2021 | $1.33B |
| Sep 30, 2020 | $0.92 | $0.68 | $0.57 - $0.78 | +35.29% | Beat | -19.3% | 15 | N/A | Oct 15, 2020 | $1.08B |
| Jun 30, 2020 | $0.37 | $0.16 | -$0.02 - $1.86 | +131.25% | Beat | -65.7% | 12 | N/A | Jul 21, 2020 | $852.10M |
| Mar 31, 2020 | $0.90 | $0.85 | $0.66 - $1.02 | +5.88% | Beat | +3.4% | 9 | N/A | Apr 16, 2020 | $1.10B |
| Dec 31, 2019 | $1.16 | $1.13 | $1.03 - $1.23 | +2.65% | Beat | +17.2% | 14 | N/A | Jan 23, 2020 | $1.28B |
| Sep 30, 2019 | $1.14 | $1.00 | $0.94 - $1.03 | +14.00% | Beat | +21.3% | 15 | N/A | Oct 17, 2019 | $1.13B |
| Jun 30, 2019 | $1.08 | $0.96 | $0.89 - $1.02 | +12.50% | Beat | +17.4% | 16 | N/A | Jul 18, 2019 | $1.10B |
| Mar 31, 2019 | $0.87 | $0.90 | $0.86 - $0.94 | -3.33% | Miss | +7.4% | 15 | N/A | Apr 18, 2019 | $973.70M |
| Dec 31, 2018 | $0.99 | $1.02 | $0.97 - $1.16 | -2.94% | Miss | +16.5% | 15 | N/A | Jan 24, 2019 | $1.05B |
| Sep 30, 2018 | $0.94 | $0.89 | $0.83 - $0.96 | +5.62% | Beat | +2.2% | 15 | N/A | Oct 18, 2018 | $920.90M |
| Jun 30, 2018 | $0.92 | $0.83 | $0.78 - $0.86 | +10.84% | Beat | +39.4% | 13 | N/A | Jul 19, 2018 | $909.30M |
| Mar 31, 2018 | $0.81 | $0.69 | $0.66 - $0.76 | +17.39% | Beat | +42.1% | 14 | N/A | Apr 17, 2018 | $847.50M |
| Dec 31, 2017 | $0.85 | $0.76 | $0.72 - $0.80 | +11.84% | Beat | +25.0% | 13 | N/A | Jan 25, 2018 | $892.00M |
| Sep 30, 2017 | $0.92 | $0.66 | $0.63 - $0.71 | +39.39% | Beat | +33.3% | 15 | N/A | Oct 19, 2017 | $807.80M |
| Jun 30, 2017 | $0.66 | $0.64 | $0.61 - $0.67 | +3.13% | Beat | +6.5% | 16 | N/A | Jul 20, 2017 | $758.80M |
| Mar 31, 2017 | $0.57 | $0.55 | N/A | +3.64% | Beat | +16.3% | N/A | N/A | Apr 18, 2017 | $679.60M |
| Dec 31, 2016 | $0.68 | $0.67 | N/A | +1.49% | Beat | +4.6% | N/A | N/A | Jan 24, 2017 | $759.00M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $8.93, up 21.8% from the year before. It was $2.48 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $8.93 | +21.8% |
| Dec 31, 2024 | $7.33 | +28.4% |
| Dec 31, 2023 | $5.71 | +21.7% |
| Dec 31, 2022 | $4.69 | -5.6% |
| Dec 31, 2021 | $4.97 | +47.0% |
| Dec 31, 2020 | $3.38 | -20.5% |
| Dec 31, 2019 | $4.25 | +16.1% |
| Dec 31, 2018 | $3.66 | +22.0% |
| Dec 31, 2017 | $3.00 | +21.0% |
| Dec 31, 2016 | $2.48 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,400 words across 14 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,352 | 14 | |
| 2026Q2 | Jun 30, 2026 | 7,843 | 13 | |
| 2026Q1 | Mar 31, 2026 | 7,104 | 9 | |
| 2025Q4 | Dec 31, 2025 | 7,782 | 10 | |
| 2025Q3 | Sep 30, 2025 | 8,717 | 11 | |
| 2025Q2 | Jun 30, 2025 | 7,677 | 10 | |
| 2025Q1 | Mar 31, 2025 | 2,400 | 10 | |
| 2024Q4 | Dec 31, 2024 | 8,289 | 11 |
2026Q3 Earnings Call
Opening remarks
Daniel Connally Head of Investor Relations Good afternoon, and welcome to Intuitive's Q3 2026 Earnings Conference Call. Joining me today are Dave Rosa, our CEO; Jamie Samath, our CFO; Dr. Jaime Wong, our Chief Medical Officer; and Gary Loeb, our Chief Legal and Compliance Officer. Before we begin, I would like to remind you that comments made on today's call may contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in our Securities and Exchange Commission filings, including our most recent 10-K filed on February 3, 2026, and 10-Q filed on July 21, 2026. Our SEC filings can be found through our website at intuitive.com or at the SEC's website. Investors are cautioned not to place undue reliance on such forward-looking statements. This conference call will be available for audio replay on our website in the Events section under our Investor Relations page. We have posted today's press release and supplementary financial data tables to our website. Our format for this afternoon's conference call is as follows: Dave will review our business and operational highlights, Jamie will review our financial results and procedure highlights, Jaime Wong will review clinical highlights, I will review our updated financial outlook for 2026, and finally, we will host a question-and-answer session. With that, I will turn it over to Dave.
David Rosa CEO Good afternoon, and thank you for joining us today. Q3 was a strong quarter for Intuitive with broad-based adoption across our multiport, single-port and Ion platforms. In Q3, total procedures increased 15%, driven by 14% growth in da Vinci procedures and 31% growth in Ion procedures. In the U.S., da Vinci procedure growth was 10%, and outside the U.S., da Vinci procedure growth was 20%. We exited the quarter with more than 13,200 da Vinci and Ion systems installed worldwide. Over time, our customers have adopted, operationalized and standardized on the da Vinci ecosystem to provide their patients with improved care. That adoption has been driven by our commitment to innovation, robust training and clinical evidence, and it is apparent in how customers use da Vinci today. In the quarter, almost 7,000 customers in more than 70 countries performed da Vinci procedures at a rate of over 10,000 procedures per day. On the clinical evidence front, more than 48,000 peer-reviewed publications have evaluated the effectiveness of da Vinci surgery, including the recent benign COMPARE study, which Jaime Wong will discuss in more detail shortly. As I described last quarter, we continue to see increasing segmentation across our customer base. Needs vary by procedure, site of care, geography and health care system.
Frequently Asked Questions About ISRG
When is Intuitive Surgical's next earnings date?
Intuitive Surgical's next earnings report is expected for Jan 20, 2027.
Did ISRG beat earnings estimates last quarter?
Yes. Intuitive Surgical reported EPS of $3.00 for the quarter ended Sep 30, 2026, above the $2.13 estimate, a 40.85% surprise.
What EPS do analysts expect from ISRG next quarter?
The consensus EPS estimate for Intuitive Surgical for the quarter ending Dec 31, 2026 is $3.01 from 30 analysts, with estimates from $2.79 to $3.19.
How often does ISRG beat earnings estimates?
Intuitive Surgical beat the EPS estimate in each of the last 15 quarters, with an average surprise of +15.00%.
ISRG pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts